What impact do Revlimid (lenalidomide) and Pomalyst (pomalidomide) have on the bone marrow? (https://www.myeloma.org/videos/impact-do-revlimidr-lenalidomide-pomalystr-pomalidomide-have-bone-marrow)
|
In this week’s video, Brian G.M. Durie explains that even though Revlimid and Pomalyst may reduce white blood cell counts, they do not permanently affect the bone marrow. BOTTOM LINE: |
Ask a Question
Please note that Ask Dr. Durie has been discontinued, and it was designed to address myeloma questions of the broadest possible audience interest. If you have a question of a personal nature, please contact our InfoLine Coordinators at 800.452.2873 or [email protected] (mailto:[email protected]) (Please do not send email attachments or lab reports.).
Dr. Brian G.M. Durie (1942-2025) was the co-founder of the IMF. He was a Professor of Medicine, Hematologist/Oncologist, and Honoree MD at the University of Brussels.